Trials / Terminated
TerminatedNCT03180853
Multiple Myeloma Patient Registry
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (actual)
- Sponsor
- Janssen Scientific Affairs, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to document the participants characteristics, disease burden, and clinical management of participants in the United States who are treated for relapsed multiple myeloma in routine medical practice with a treatment strategies that include a proteasome inhibitor (PI) and/or immunomodulatory drug (IMiD) used either as monotherapy or combination therapy with other treatments.
Conditions
Timeline
- Start date
- 2017-05-08
- Primary completion
- 2018-04-06
- Completion
- 2018-04-06
- First posted
- 2017-06-08
- Last updated
- 2025-02-03
Locations
69 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03180853. Inclusion in this directory is not an endorsement.